Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. Additionally we are shipping KCNJ2 Proteins (5) and many more products for this protein.
Showing 10 out of 92 products:
Human Monoclonal KCNJ2 Primary Antibody for AA, ICC - ABIN2483544
Donaldson, Yoon, Fu, Ptacek: Andersen-Tawil syndrome: a model of clinical variability, pleiotropy, and genetic heterogeneity. in Annals of medicine 2004
Human Polyclonal KCNJ2 Primary Antibody for IHC, ELISA - ABIN1534992
Wood, Tsai, Lee, Vogeli: Cloning and functional expression of a human gene, hIRK1, encoding the heart inward rectifier K+-channel. in Gene 1995
These findings suggest that KCNJ2 plays an important role in the pathophysiology of Thyrotoxic Periodic Paralysis in Korean Graves' Disease patients with Thyrotoxic Periodic Paralysis .
Nav1.5 (show SCN5A Antibodies) N-terminal domain binding to alpha1-syntrophin (show SNTA1 Antibodies) increases membrane density of human Kir2.1, Kir2.2 (show KCNJ12 Antibodies) and Nav1.5 (show SCN5A Antibodies) channels
Kir2.1 may participate in macrophage maturation and differentiation, and play a key role in lipid uptake and foam cell formation through modulating the expression of scavenger receptors.
a Korean family with Andersen-Tawil syndrome with a G215D mutation of the KCNJ2 gene revealed by diagnostic exome sequencing, is reported.
Chloroethylclonidine interact with Kir2.1 channels in the cytoplasmic pore.
Variability has been found in a three-generation family with Pierre Robin sequence, acampomelic campomelic dysplasia, and intellectual disability due to a novel approximately 1 Mb deletion upstream of SOX9 (show SOX9 Antibodies), and including KCNJ2 and KCNJ16 (show KCNJ16 Antibodies).
Patients with Dilated Cardiomyopathy and Sustained Monomorphic Ventricular Tachycardia Show Up-Regulation of KCNN3 (show KCNN3 Antibodies) and KCNJ2 Genes and CACNG8 (show CACNG8 Antibodies)-Linked Left Ventricular Dysfunction
Results indicate that silencing BKCa (KCa1.1 (show KCNMA1 Antibodies)) inhibits cell mobility, while silencing IKir (Kir2.1) increases cell mobility in human cardiac c-kit (show KIT Antibodies)+ progenitor cells.
No genetic variants were identified in the KCNJ2 gene in this cohort of Chinese thyrotoxic periodic paralysis patients.
Kir2.1 channels exhibit a binding site determined by Cys311 that is responsible for drug-induced increases in inward rectifier Kir2.1 currents.
Intracellular Mg(2 (show MCOLN1 Antibodies)+) and SPM (show NPC1 Antibodies) therefore may have a synergistic action on the pore-blocking effect, presumably via prohibition of the outward exit of the higher-affinity blocking SPM (show NPC1 Antibodies) by the lower-affinity Mg(2 (show MCOLN1 Antibodies)+).
Consistent with a role of the K(+) current in amplifying the sensory response, entry of protons through the Zn(2+)-sensitive conductance produces a transient block of the KIR2.1 current.
Mouse neutrophils express functional Kir2.1 channels from bone marrow and liver.
A184R mutation in the inner end of the bundle crossing region of Kir2.1 not only abolishes the inward rectifying features of spermine block but also tends to close the channel pore.
the present work demonstrates that a functional Kir2.1-like channel is expressed in lactating mouse mammary secretory cells.
Kir2.1 mRNA levels were downregulated by LPS (show TLR4 Antibodies), and to a lesser extent by IL-4 (show IL4 Antibodies)/IL-13 (show IL13 Antibodies).
Report pentamidine analogue which specifically blocks cardiac KIR2.1 channel, lengthening action potential duration.
The total Kcnj2 (gene for the Kir2.1 potassium channel (show KCNAB2 Antibodies)) mRNA was reduced in Huntington disease (show HTT Antibodies) skeletal muscle.
miR (show MLXIP Antibodies)-26 controls the expression of KCNJ2 and may have a role in atrial fibrillation
Stronger expressions of SCN5a (show SCN5A Antibodies), SCN1b (show SCN1B Antibodies) and Kir2.1 were observed in ventricular-like and atrial-like cells compared to that of pacemaker-like cardiomyocytes.
Kir2.1 may mediate native Kir (show GEM Antibodies) currents responsible for setting resting membrane potential in bovine parotid cells and might be, at least in part, involved in spontaneous secretion in ruminant parotid glands.
There were substantial transmural gradients in Cav1.2 (show CACNA1C Antibodies), KChIP2 (show KCNIP2 Antibodies), ERG (show KCNH2 Antibodies), KvLQT1 (show KCNQ1 Antibodies), Kir2.1, NCX1 (show SLC8A1 Antibodies), SERCA2a (show ATP2A2 Antibodies) and RyR2 (show RYR2 Antibodies) at the mRNA and, in some cases, protein level-in every case the mRNA or protein was more abundant in the epicardium than the endocardium.
Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. The protein encoded by this gene is an integral membrane protein and inward-rectifier type potassium channel. The encoded protein, which has a greater tendency to allow potassium to flow into a cell rather than out of a cell, probably participates in establishing action potential waveform and excitability of neuronal and muscle tissues. Mutations in this gene have been associated with Andersen syndrome, which is characterized by periodic paralysis, cardiac arrhythmias, and dysmorphic features.
, inward rectifier K(+) channel Kir2.1
, inward rectifier potassium channel 2
, potassium channel, inwardly rectifying subfamily J member 2
, cardiac inward rectifier potassium channel
, inward rectifier K+ channel KIR2.1
, inward rectifier potassium channel cIRK1
, cardiac inward rectifier KIR2.1
, inwardly rectifying potassium channel Kir2.1
, inward rectifier potassium channel Kir2.1
, inwardly-rectifying potassium channel Kir2.1